A clinical AI company managing chronic care for older adults.
A clinical AI company managing chronic care for older adults. Headquartered in New York City, NY. Raised $100M in Series C funding in June 2026 led by Spark Capital.
Healthcare📍 New York City, NY
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Cadence going public?
No. Cadence is private and has not filed to go public. There is no S-1 on file.
What is Cadence's valuation in 2026?
No confirmed valuation is on record for Cadence. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Cadence filed an S-1?
No public S-1 is on file for Cadence.
Who are Cadence's investors?
Cadence's investors include Spark Capital, Thrive Capital, General Catalyst, Coatue, B Capital, Corewell Health Ventures and 2 more.
How much has Cadence raised?
Cadence has raised $100M in total across 1 disclosed round, most recently a Series C of $100M in Jun 2026.
Is Cadence publicly traded — can you buy Cadence stock?
No. Cadence is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Cadence on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
CEO
Chris Altchek
HQ
New York City, NY
Total Raised
$100M
Last Round
Series C — $100M (Jun 2026) · Lead: Spark Capital
IPO Status
private
Fundraising Status
Series C · $100M · 3 mo ago
privateTotal raised $100M1 disclosed rounds
Funding History
Round
Amount
Date
Lead Investor
Post-Money
Series C
$100M
Jun 2026
Spark Capital
—
Vertical Intelligence — AI / ML
No verified Hugging Face organization found for Cadence — no attributable open-model footprint. Closed-weights labs are common; this is a distribution signal, not a capability judgment.
Checked huggingface.co as of 2026-09-19. Re-checked weekly.
Talent Signal
Hiring trend
▲ Hiring uptrend
+2300% vs 2026-08
Open roles
120
via workday
Product-build share
81%
engineering, research, product, design
Trajectory
expanding
heavy product build — 81% of open roles are product-building functions (engineering/research/product) — 68 of 120 open roles are engineering.
No tracked executive churn; open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Lead Product Engineer - Low Power EmulationIT -Staff Systems Engineer - VMSoftware Engineer IIMixed-Signal, Sr Principal Design EngineerSoftware Engineer IIProduct Engineer II
Counted from Cadence's live job board as of 2026-09-14; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Investors
Spark Capital · Thrive Capital · General Catalyst · Coatue · B Capital · Corewell Health Ventures · Memorial Hermann · Duke Health
HealthcareAI / Chronic CareRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.